植込み型除細動器（ICD）の世界市場レポート 2025年

植込み型除細動器（ICD）市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.8％で49億9,000万米ドルに成長します。予測期間中に予想される成長は、植え込み型除細動器の受け入れ拡大、個別化された心臓ケアに対する需要の高まり、心臓リズム障害の有病率の増加、新興市場における需要の高まりに起因しています。予測期間を形成すると予想される主な動向には、技術革新、経静脈リードを不要とする皮下ICDの開発、ペースメーカー機能を備えたICD併用型機器の需要増加、センシングおよび検出アルゴリズムの改善、ワイヤレス充電およびバッテリー技術の継続的な進歩、ヘルスケアにおける人工知能（AI）およびデータ分析の統合などが含まれます。

心血管疾患（CVDs）の有病率の増加は、今後数年間の植込み型除細動器（ICD）市場の拡大を牽引すると予想されます。CVDは心臓や血管に影響を与えるさまざまな疾患で、心臓発作、脳卒中、高血圧などの疾患が含まれます。これらの疾患は、食生活の乱れ、座りがちなライフスタイル、喫煙、遺伝的素因などの要因と関連していることが多いです。心血管系疾患の増加は、主に人口の高齢化、不健康な生活習慣、肥満、糖尿病、高血圧などの危険因子の増加によるものです。ICDは、突然の心停止の危険性がある人に救命のための電気ショックを与え、正常な心臓のリズムを回復させることで、CVDの管理に重要な役割を果たしています。例えば、2023年12月、オーストラリア保健福祉研究所は、冠動脈性心疾患（CHD）による医師認定死亡者数の増加を報告し、2021年の1万4,100人から2022年には1万4,900人に増加しました。したがって、心血管疾患の有病率の増加がICD市場の成長を促進しています。

植込み型除細動器（ICD）市場の主要企業は、機器性能の向上、電池寿命の延長、患者の快適性の向上を図るため、低消費電流型除細動器などの技術革新に注力しています。これらの除細動器は、少ない消費電力で心臓に電気ショックを与えるように設計されており、それによってバッテリーの寿命を延ばし、不整脈の効果的な治療を保証しています。例えば、2023年10月、フランスの医療機器メーカーであるマイクロポートCRM社は、植込み型除細動器（ICD）ULYSと除細動リードINVICTAを日本で発表し、心臓治療技術における重要なマイルストーンとなりました。これらの装置には、電池寿命を延ばすための低消費電流や、画像診断が必要な患者のためのMRI対応などの先進機能が組み込まれています。また、ULYS ICDにはPARAD+不整脈識別アルゴリズムとAutoMRI機能が搭載されており、MRI検査時の患者の安全性を向上させます。さらに、INVICTAリードは臨床試験において、100％の植込み成功率と97.4％の合併症なし率を実証し、その高い信頼性と有効性を示しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界植込み型除細動器（ICD） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の植込み型除細動器（ICD）市場：成長率分析
• 世界の植込み型除細動器（ICD）市場の実績：規模と成長, 2019-2024
• 世界の植込み型除細動器（ICD）市場の予測：規模と成長, 2024-2029, 2034F
• 世界植込み型除細動器（ICD）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の植込み型除細動器（ICD）市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シングルチャンバー植込み型除細動器（ICD）
• デュアルチャンバー植込み型除細動器（ICD）
• 両室デバイス
• 世界の植込み型除細動器（ICD）市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 徐脈
• 頻脈
• 心不全
• その他の用途
• 世界の植込み型除細動器（ICD）市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 外来手術センター
• その他のエンドユーザー
• 世界の植込み型除細動器（ICD）市場単腔植込み型除細動器（ICD）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準シングルチャンバーICD
• MRI対応シングルチャンバーICD
• ワイヤレスシングルチャンバーICD
• 世界の植込み型除細動器（ICD）市場二腔植込み型除細動器（ICD）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準デュアルチャンバーICD
• MRI対応デュアルチャンバーICD
• ワイヤレスデュアルチャンバーICD
• 世界の植込み型除細動器（ICD）市場、両心室デバイスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• CRT-D（心臓再同期療法除細動器）
• CRT-P（心臓再同期療法ペースメーカー）
• 高度な機能（リモートモニタリング、ワイヤレス機能）を備えた両心室ICD

第7章 地域別・国別分析

• 世界の植込み型除細動器（ICD）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の植込み型除細動器（ICD）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 植込み型除細動器（ICD）市場：競合情勢
• 植込み型除細動器（ICD）市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • ZOLL Medical Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• St. Jude Medical Inc.
• BIOTRONIK SE & Co. KG
• Nihon Kohden Corporation
• Fukuda Denshi Co. Ltd.
• LivaNova PLC
• MicroPort Scientific Corporation
• Japan Lifeline Co. Ltd.
• AtriCure Inc.
• Physio-Control Inc.
• BPL Medical Technologies Private Limited
• Kestra Medical Technologies Inc.
• CU Medical Germany GmbH
• Metrax GmbH
• Intermedics Inc.
• Sorin Group S.p.A.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 植込み型除細動器（ICD）市場2029：新たな機会を提供する国
• 植込み型除細動器（ICD）市場2029：新たな機会を提供するセグメント
• 植込み型除細動器（ICD）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Implantable cardioverter defibrillators (ICDs) are compact devices placed beneath the skin, usually near the chest area. They are designed to monitor the heart's rhythm and administer electrical shocks when a life-threatening arrhythmia, such as ventricular fibrillation, is identified. The primary goal of ICDs is to prevent sudden cardiac arrest by restoring a normal heart rhythm.

There are several types of implantable cardioverter defibrillators (ICDs), including single-chamber ICDs, dual-chamber ICDs, and biventricular devices. A single-chamber ICD is implanted in the chest and is responsible for detecting and correcting abnormal heart rhythms in one of the heart's chambers. This device serves various purposes, such as managing bradycardia, tachycardia, and heart failure, and is utilized in different settings, including hospitals, specialty clinics, ambulatory surgical centers, and more.

The implantable cardioverter defibrillators (ICDs) market research report is one of a series of new reports from The Business Research Company that provides implantable cardioverter defibrillators (ICDs) market statistics, including the implantable cardioverter defibrillators (ICDs) industry global market size, regional shares, competitors with the implantable cardioverter defibrillators (ICDs) market share, detailed implantable cardioverter defibrillators (ICDs) market segments, market trends, and opportunities, and any further data you may need to thrive in the implantable cardioverter defibrillators (ICDs) industry. This implantable cardioverter defibrillators (ICDs) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The implantable cardioverter defibrillators (ICDs) market size has grown strongly in recent years. It will grow from $3.76 billion in 2024 to $3.99 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth observed during the historical period can be linked to several factors, including the rising incidence of sudden cardiac arrest, the integration of implantable cardioverter defibrillators in the secondary prevention of such events, enhanced public awareness, the aging population, favorable policies from governments and healthcare organizations, and improved access to healthcare.

The implantable cardioverter defibrillators (ICDs) market size is expected to see strong growth in the next few years. It will grow to $4.99 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The anticipated growth during the forecast period can be attributed to the increasing acceptance of implantable defibrillators, a higher demand for personalized cardiac care, the growing prevalence of cardiac rhythm disorders, and the rising demand in emerging markets. Key trends expected to shape the forecast period include technological innovations, the development of subcutaneous ICDs that eliminate the need for transvenous leads, a rising demand for combination ICD devices with pacemaker capabilities, improvements in sensing and detection algorithms, ongoing progress in wireless charging and battery technologies, and the integration of artificial intelligence (AI) and data analytics in healthcare.

The growing prevalence of cardiovascular diseases (CVDs) is expected to drive the expansion of the implantable cardioverter defibrillators (ICDs) market in the coming years. CVDs are a range of disorders that impact the heart and blood vessels, including conditions such as heart attacks, strokes, and hypertension. These diseases are often linked to factors such as poor diet, sedentary lifestyle, smoking, and genetic predisposition. The rise in cardiovascular diseases is mainly attributed to aging populations, unhealthy lifestyle habits, and increasing rates of risk factors such as obesity, diabetes, and hypertension. ICDs play a critical role in managing CVDs by delivering life-saving electrical shocks to restore normal heart rhythms in individuals at risk of sudden cardiac arrest. For example, in December 2023, the Australian Institute of Health and Welfare reported a rise in doctor-certified deaths due to coronary heart disease (CHD), which increased from 14,100 in 2021 to 14,900 in 2022. Therefore, the increasing prevalence of cardiovascular diseases is fueling the growth of the ICD market.

Leading companies in the implantable cardioverter defibrillators (ICDs) market are concentrating on technological innovations, such as low current consumption defibrillators, to improve device performance, extend battery life, and enhance patient comfort. These defibrillators are designed to administer electrical shocks to the heart while using less energy, thereby increasing battery longevity and ensuring effective treatment of arrhythmias. For example, in October 2023, MicroPort CRM, a medical device company based in France, introduced the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead in Japan, marking a significant milestone in cardiac care technology. These devices incorporate advanced features such as low current consumption to extend battery life and MRI compatibility for patients requiring imaging procedures. The ULYS ICD also includes the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, improving patient safety during MRI scans. Moreover, the INVICTA lead demonstrated a 100% implantation success rate and a 97.4% complication-free rate in clinical trials, showcasing its high reliability and effectiveness.

In June 2023, Royal Philips, a health technology company based in the Netherlands, joined forces with Biotronik to broaden the range of cardiovascular devices available to users of Philips SymphonySuite, a leading solution designed for cardiovascular office-based labs (OBLs) and ambulatory surgery centers (ASCs). The collaboration integrates Philips SymphonySuite with Biotronik's comprehensive selection of cardiac rhythm management and cardiovascular intervention products, thereby improving options for personalized patient care and supporting the shift towards out-of-hospital care settings. Biotronik, a US-based medical device company, specializes in providing products and services that aim to enhance the quality of life for patients with cardiovascular and endovascular conditions.

Major players in the implantable cardioverter defibrillators (ICDs) market are Abbott Laboratories, Medtronic Inc., Koninklijke Philips N.V., Boston Scientific Corporation, ZOLL Medical Corporation, St. Jude Medical Inc., BIOTRONIK SE & Co. KG, Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., LivaNova PLC, MicroPort Scientific Corporation, Japan Lifeline Co. Ltd., AtriCure Inc., Physio-Control Inc., BPL Medical Technologies Private Limited, Kestra Medical Technologies Inc., CU Medical Germany GmbH, Metrax GmbH, Intermedics Inc., and Sorin Group S.p.A.

North America was the largest region in the implantable cardioverter defibrillators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in implantable cardioverter defibrillators (ICDs) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the implantable cardioverter defibrillators (ICDs) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable cardioverter defibrillators (ICDs) market consists of sales of therapy defibrillators, rechargeable and non-rechargeable batteries, programming devices, implantation tools, electrodes, and leads. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Cardioverter Defibrillators (ICDs) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable cardioverter defibrillators (icds) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable cardioverter defibrillators (icds) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable cardioverter defibrillators (icds) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs); Dual Chamber Implantable Cardioverter Defibrillators (ICDs); Biventricular Devices
• 2) By Applications: Bradycardia; Tachycardia; Heart Failure; Other Applications
• 3) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs; MRI-Compatible Single Chamber ICDs; Wireless Single Chamber ICDs
• 2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs; MRI-Compatible Dual Chamber ICDs; Wireless Dual Chamber ICDs
• 3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator); CRT-P (Cardiac Resynchronization Therapy Pacemaker); Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)
• Companies Mentioned: Abbott Laboratories; Medtronic Inc.; Koninklijke Philips N.V.; Boston Scientific Corporation; ZOLL Medical Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Cardioverter Defibrillators (ICDs) Market Characteristics

3. Implantable Cardioverter Defibrillators (ICDs) Market Trends And Strategies

4. Implantable Cardioverter Defibrillators (ICDs) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Implantable Cardioverter Defibrillators (ICDs) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Implantable Cardioverter Defibrillators (ICDs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Implantable Cardioverter Defibrillators (ICDs) Market Growth Rate Analysis
• 5.4. Global Implantable Cardioverter Defibrillators (ICDs) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Implantable Cardioverter Defibrillators (ICDs) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Implantable Cardioverter Defibrillators (ICDs) Total Addressable Market (TAM)

6. Implantable Cardioverter Defibrillators (ICDs) Market Segmentation

• 6.1. Global Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Chamber Implantable Cardioverter Defibrillators (ICDs)
• Dual Chamber Implantable Cardioverter Defibrillators (ICDs)
• Biventricular Devices
• 6.2. Global Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bradycardia
• Tachycardia
• Heart Failure
• Other Applications
• 6.3. Global Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Other End Users
• 6.4. Global Implantable Cardioverter Defibrillators (ICDs) Market, Sub-Segmentation Of Single Chamber Implantable Cardioverter Defibrillators (ICDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Single Chamber ICDs
• MRI-Compatible Single Chamber ICDs
• Wireless Single Chamber ICDs
• 6.5. Global Implantable Cardioverter Defibrillators (ICDs) Market, Sub-Segmentation Of Dual Chamber Implantable Cardioverter Defibrillators (ICDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Dual Chamber ICDs
• MRI-Compatible Dual Chamber ICDs
• Wireless Dual Chamber ICDs
• 6.6. Global Implantable Cardioverter Defibrillators (ICDs) Market, Sub-Segmentation Of Biventricular Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRT-D (Cardiac Resynchronization Therapy Defibrillator)
• CRT-P (Cardiac Resynchronization Therapy Pacemaker)
• Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)

7. Implantable Cardioverter Defibrillators (ICDs) Market Regional And Country Analysis

• 7.1. Global Implantable Cardioverter Defibrillators (ICDs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Implantable Cardioverter Defibrillators (ICDs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market

• 8.1. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Cardioverter Defibrillators (ICDs) Market

• 9.1. China Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 9.2. China Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Cardioverter Defibrillators (ICDs) Market

• 10.1. India Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Cardioverter Defibrillators (ICDs) Market

• 11.1. Japan Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 11.2. Japan Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Cardioverter Defibrillators (ICDs) Market

• 12.1. Australia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market

• 13.1. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Cardioverter Defibrillators (ICDs) Market

• 14.1. South Korea Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 14.2. South Korea Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market

• 15.1. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 15.2. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Cardioverter Defibrillators (ICDs) Market

• 16.1. UK Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Cardioverter Defibrillators (ICDs) Market

• 17.1. Germany Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Cardioverter Defibrillators (ICDs) Market

• 18.1. France Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Cardioverter Defibrillators (ICDs) Market

• 19.1. Italy Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Cardioverter Defibrillators (ICDs) Market

• 20.1. Spain Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market

• 21.1. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 21.2. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Cardioverter Defibrillators (ICDs) Market

• 22.1. Russia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Cardioverter Defibrillators (ICDs) Market

• 23.1. North America Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 23.2. North America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Cardioverter Defibrillators (ICDs) Market

• 24.1. USA Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 24.2. USA Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Cardioverter Defibrillators (ICDs) Market

• 25.1. Canada Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 25.2. Canada Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Cardioverter Defibrillators (ICDs) Market

• 26.1. South America Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 26.2. South America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Cardioverter Defibrillators (ICDs) Market

• 27.1. Brazil Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Cardioverter Defibrillators (ICDs) Market

• 28.1. Middle East Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 28.2. Middle East Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Cardioverter Defibrillators (ICDs) Market

• 29.1. Africa Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 29.2. Africa Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Cardioverter Defibrillators (ICDs) Market Competitive Landscape And Company Profiles

• 30.1. Implantable Cardioverter Defibrillators (ICDs) Market Competitive Landscape
• 30.2. Implantable Cardioverter Defibrillators (ICDs) Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. ZOLL Medical Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Cardioverter Defibrillators (ICDs) Market Other Major And Innovative Companies

• 31.1. St. Jude Medical Inc.
• 31.2. BIOTRONIK SE & Co. KG
• 31.3. Nihon Kohden Corporation
• 31.4. Fukuda Denshi Co. Ltd.
• 31.5. LivaNova PLC
• 31.6. MicroPort Scientific Corporation
• 31.7. Japan Lifeline Co. Ltd.
• 31.8. AtriCure Inc.
• 31.9. Physio-Control Inc.
• 31.10. BPL Medical Technologies Private Limited
• 31.11. Kestra Medical Technologies Inc.
• 31.12. CU Medical Germany GmbH
• 31.13. Metrax GmbH
• 31.14. Intermedics Inc.
• 31.15. Sorin Group S.p.A.

32. Global Implantable Cardioverter Defibrillators (ICDs) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Cardioverter Defibrillators (ICDs) Market

34. Recent Developments In The Implantable Cardioverter Defibrillators (ICDs) Market

35. Implantable Cardioverter Defibrillators (ICDs) Market High Potential Countries, Segments and Strategies

• 35.1 Implantable Cardioverter Defibrillators (ICDs) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Implantable Cardioverter Defibrillators (ICDs) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Implantable Cardioverter Defibrillators (ICDs) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer